|
1
|
Umeda M, Komatsubara H, Ojima Y,
Minamikawa T, Shigeta T, Shibuya Y, Yokoo S and Komori T: Lack of
survival advantage in patients with advanced, resectable squamous
cell carcinoma of the oral cavity receiving induction chemotherapy
with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU).
Kobe J Med Sci. 50:189–196. 2004.PubMed/NCBI
|
|
2
|
Katori H, Tsukuda M, Mochimatu I, Ishitoya
J, Kawai S, Mikami Y, Matsuda H, Tanigaki Y, Horiuchi C, Ikeda Y,
et al: Phase I trial of concurrent chemoradiotherapy with
docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with
locally advanced squamous cell carcinoma of the head and neck
(SCCHN). Br J Cancer. 90:348–352. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ahn JS, Cho SH, Kim OK, Lee JK, Yang DH,
Kim YK, Lee JJ, Lim SC, Kim HJ, Chung WK and Chung IJ: The efficacy
of an induction chemotherapy combination with docetaxel, cisplatin
and 5-FU followed by concurrent chemoradiotherapy in advanced head
and neck cancer. Cancer Res Treat. 39:93–98. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fuwa N, Ito Y, Matsumoto A, Kamata M,
Kodaira T, Furutani K, Sasaoka M, Kimura Y and Morita K: A
combination therapy of continuous superselective intraarterial
carboplatin infusion and radiation therapy for locally advanced
head and neck carcinoma. Phase I study. Cancer. 89:2099–2105. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kobayashi H, Tanisaka K, Kondo N, Mito Y,
Koezuka M, Yokouchi H, Higashiyama M, Kodama K, Doi O, Yamada M, et
al: Development of new in vitro chemosensitivity test using
collagen gel droplet embedded culture and its clinical usefulness.
Gan To Kagaku Ryoho. 22:1933–1939. 1995.(In Japanese). PubMed/NCBI
|
|
6
|
Kobayashi H, Tanisaka K, Doi O, Kodama K,
Higashiyama M, Nakagawa H, Miyake M, Taki T, Hara S, Yasutomi M, et
al: An in vitro chemosensitivity test for solid human tumors using
collagen gel droplet embedded cultures. Int J Oncol. 11:449–455.
1997.PubMed/NCBI
|
|
7
|
Naitoh H, Yamamoto H, Murata S, Kobayashi
H, Inoue K and Tani T: Stratified phase II trial to establish the
usefulness of the collagen gel droplet embedded culture-drug
sensitivity test (CD-DST) for advanced gastric cancer. Gastric
Cancer. 17:630–637. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ochiai T, Nishimura K, Watanabe T,
Kitajima M, Nakatani A, Inou T, Washio M, Sakuyama N, Sato T,
Kishine K, et al: Individualized chemotherapy for colorectal cancer
based on the collagen gel droplet-embedded drug sensitivity test.
Oncol Lett. 4:621–624. 2012.PubMed/NCBI
|
|
9
|
Mekata E, Sonoda H, Shimizu T, Tatsuta T,
Yamaguchi T, Endo Y and Tani T: Clinical predictive value of in
vitro anticancer drug sensitivity test for the therapeutic effect
of adjuvant chemotherapy in patients with stage II–III colorectal
cancer. Mol Clin Oncol. 1:763–767. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sakuma K, Tanaka A and Mataga I: Collagen
gel droplet-embedded culture drug sensitivity testing in squamous
cell carcinoma cell lines derived from human oral cancers: Optimal
contact concentrations of cisplatin and fluorouracil. Oncol Lett.
12:4643–4650. 2016.PubMed/NCBI
|
|
11
|
Takamura Y, Kobayashi H, Taguchi T,
Motomura K, Inaji H and Noguchi S: Prediction of chemotherapeutic
response by collagen gel droplet embedded culture-drug sensitivity
test in human breast cancers. Int J Cancer. 98:450–455. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Inuyama Y and Takeda C: A cooperative
phase II study of cisplatin in patients with head and neck cancer.
Gan To Kagaku Ryoho. 13:232–238. 1986.(In Japanese). PubMed/NCBI
|
|
14
|
Jacobs C, Lyman G, Velez-García E, Sridhar
KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH,
Schacter L, et al: A phase III randomized study comparing cisplatin
and fluorouracil as single agents and in combination for advanced
squamous cell carcinoma of the head and neck. J Clin Oncol.
10:257–263. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Inuyama Y, Kataura A, Togawa K, Saijo S,
Satake B, Takeoda S, Konno A, Ebihara S, Sasaki Y, Kida A, et al:
Late phase II clinical study of RP56976 (docetaxel) in patients
with advanced/recurrent head and neck cancer. Gan To Kagaku Ryoho.
26:107–116. 1999.(In Japanese). PubMed/NCBI
|
|
16
|
Zhong LP, Zhang CP, Ren GX, Guo W, William
WN Jr, Sun J, Zhu HG, Tu WY, Li J, Cai Y, et al: Randomized phase
III trial of induction chemotherapy with docetaxel, cisplatin and
fluorouracil followed by surgery versus up-front surgery in locally
advanced resectable oral squamous cell carcinoma. J Clin Oncol.
31:744–751. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vermorken JB, Mesia R, Rivera F, Remenar
E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol
D, et al: Platinum-based chemotherapy plus cetuximab in head and
neck cancer. N Engl J Med. 359:1116–1127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kiyota N, Tahara M, Kadowaki S, Fuse N,
Doi T, Minami H and Ohtsu A: Systemic chemotherapy with cisplatin
plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma
of the head and neck (R/M SCCHN): Efficacy and safety of a lower
dose of PF (80/800) at a single institution in Japan. Jpn J Clin
Oncol. 39:225–230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Robbins KT, Kumar P, Harris J, McCulloch
T, Cmelak A, Sofferman R, Levine P, Weisman R, Wilson W, Weymuller
E and Fu K: Supradose intra-arterial cisplatin and concurrent
radiation therapy for the treatment of stage IV head and neck
squamous cell carcinoma is feasible and efficacious in a
multi-institutional setting: Results of Radiation Therapy Oncology
Group Trial 9615. J Clin Oncol. 23:1447–1454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Robbins KT, Kumar P, Regine WF, Wong FS,
Weir AB III, Flick P, Kun LE, Palmer R, Murry T, Fontanesi J, et
al: Efficacy of targeted supradose cisplatin and concomitant
radiation therapy for advanced head and neck cancer: The memphis
experience. Int J Radiat Oncol Biol Phys. 38:263–271. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vermorken JB, Remenar E, van Herpen C,
Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss
JH, et al: Cisplatin, fluorouracil, and docetaxel in unresectable
head and neck cancer. N Engl J Med. 357:1695–1704. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Posner MR, Hershock DM, Blajman CR,
Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM,
Cullen K, Ervin TJ, et al: Cisplatin and fluorouracil alone or with
docetaxel in head and neck cancer. N Engl J Med. 357:1705–1715.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Salmon SE, Hamburger AW, Soehnlen B, Durie
BG, Alberts DS and Moon TE: Quantitation of differential
sensitivity of human-tumor stem cells to anticancer drugs. N Engl J
Med. 298:1321–1327. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kondo T, Lmamura T and Lchibashi H: In
vitro test for sensitivity of tumor to carcinostatic agents. Gan.
57:113–121. 1966.PubMed/NCBI
|
|
25
|
Inaba M, Tashiro T, Sato S, Ohnishi Y,
Tanisaka K, Kobayashi H and Koezuka M: In vitro-in vivo correlation
in anticancer drug sensitivity test AUC-based concentrations and
collagen gel droplet embedded culture. Oncology. 53:250–257. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Araki Y, Isomoto H, Matsumoto A, Kaibara
A, Yasunaga M, Hayashi K, Yatsugi H and Yamauchi K: An in vitro
chemosensitivity test for colorectal cancer using collagen-gel
droplet embedded cultures. Kurume Med J. 46:163–166. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kawamura M, Inoue Y, Oyama T and Kobayashi
K: Chemosensitivity test for uresectable non-small cell lung
cancer. Nihon Geka Gakkai Zasshi. 103:229–232. 2002.(In Japanese).
PubMed/NCBI
|
|
28
|
Yamamoto Y, Watanabe Y, Ishida N, Hidaka
T, Sugishita H, Yoshida M, Yukumi S, Sato K, Nakagawa H, Horiuchi A
and Kawachi K: Collagen gel droplet-embedded culture drug
sensitivity test in human breast cancer. Gan To Kagaku Ryoho.
35:793–796. 2008.PubMed/NCBI
|
|
29
|
Nakagawa T, Takahashi H, Kamiyama T,
Nakanishi K, Takahashi M, Watanabe K, Taguchi K, Tsukahara M,
Nakajima H, Kamachi H, et al: In vitro chemosensitivity test for
hepatocellular carcinoma using collagen-gel droplet embedded
cultures. Gan To Kagaku Ryoho. 31:2145–2149. 2004.(In Japanese).
PubMed/NCBI
|
|
30
|
Suzuki M, Ishikawa H, Tanaka A and Mataga
I: Heterogeneity of anticancer drug sensitivity in squamous cell
carcinoma of the tongue. Hum Cell. 24:21–29. 2011. View Article : Google Scholar : PubMed/NCBI
|
